{"disease":{"id":"cmv-infection","name":"cmv infection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03486834","title":"V160 2-Dose and 3-Dose Regimens in Healthy Cytomegalovirus (CMV) Seronegative Females (V160-002)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":2200,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT07443501","title":"Reducing Post-Letermovir CMV Infection: Efficacy of an Immune-Reconstitution-Based Scoring System to Guide Prophylaxis Duration","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":1114,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT06226558","title":"Long-Term Outcomes of Children With Congenital CMV in New York State","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"Stony Brook University","has_results":false},{"nct_id":"NCT05958186","title":"A Study of Cytomegalovirus Disease Epidemiology in Pediatric and Adult Liver Transplant Recipients in China","phase":"","overall_status":"COMPLETED","enrollment_count":800,"lead_sponsor_name":"Lin Zhong","has_results":true},{"nct_id":"NCT02137772","title":"Letermovir (MK-8228) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":570,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT06263218","title":"Real-world CMV Outcomes Among Kidney Transplant Recipients in Brazil","phase":"","overall_status":"UNKNOWN","enrollment_count":500,"lead_sponsor_name":"Hospital do Rim e Hipertensão","has_results":false},{"nct_id":"NCT05315882","title":"Cytomegalovirus Infection After HSCT and PT-CY as GVHD Prophylaxis >> GVHD PROPHYLAXIS ERA","phase":"","overall_status":"COMPLETED","enrollment_count":300,"lead_sponsor_name":"Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud","has_results":false},{"nct_id":"NCT05789615","title":"Letermovir Prophylaxis for CMV Infection in Haplo-HSCT Recipients: Single-center Data in China","phase":"","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT04278547","title":"Multicenter Clinical Trial to Evaluate the Efficacy of a Preventive Strategy Against CMV Infection in Heart Transplant Patients, Based on the Specific T Cells Response","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":188,"lead_sponsor_name":"Hospital Universitari de Bellvitge","has_results":false},{"nct_id":"NCT03858907","title":"Cytomegalovirus Risk in Seropositive Kidney Transplant Recipients Stratified by Quantiferon-CMV","phase":"","overall_status":"UNKNOWN","enrollment_count":180,"lead_sponsor_name":"University of Sao Paulo General Hospital","has_results":false},{"nct_id":"NCT04021628","title":"Cytomegalovirus Shedding Characteristics in Pregnant Women","phase":"","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"St George's, University of London","has_results":true},{"nct_id":"NCT06362720","title":"The Comparison the CMV Infection and Reactivation After Allogeneic Hematopoietic Stem Cell Transplantation Between Standard Regimen, Methotrexate Plus Cyclosporin A, and Post-transplant Cyclophosphamide-based Regimen","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":158,"lead_sponsor_name":"Siriraj Hospital","has_results":false},{"nct_id":"NCT07079735","title":"Valganciclovir vs. Letermovir for CMV Prophylaxis in Heart Transplant","phase":"PHASE2, PHASE3","overall_status":"RECRUITING","enrollment_count":150,"lead_sponsor_name":"Columbia University","has_results":false},{"nct_id":"NCT06306989","title":"Observational Clinical Study of Letermovir for Preventing CMV Infection After Allo-HSCT","phase":"","overall_status":"UNKNOWN","enrollment_count":150,"lead_sponsor_name":"Cao Weijie","has_results":false},{"nct_id":"NCT07450365","title":"Evaluation of Long-term Efficacy of 4 to 6-month Course Antiviral Therapy for Neurodevelopmental Impairments Caused by Congenital Cytomegalovirus Infection","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Hu Bofei","has_results":false},{"nct_id":"NCT07379203","title":"ValgaNciclovIR for CMV Viraemia in AdvaNced HIV diseAse","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":130,"lead_sponsor_name":"Wits Health Consortium (Pty) Ltd","has_results":false},{"nct_id":"NCT07513623","title":"Systemic and Topical Antiviral Control of Cytomegalovirus Anterior Uveitis: Treatment Outcomes - Trials I and II","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":117,"lead_sponsor_name":"University of California, San Francisco","has_results":false},{"nct_id":"NCT04017962","title":"A Study of the Drug Letermovir (LTV) as Prevention for Recurrent of Cytomegalovirus (CMV) Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":102,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT03159364","title":"Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":100,"lead_sponsor_name":"Shenzhen Geno-Immune Medical Institute","has_results":false},{"nct_id":"NCT06853184","title":"Study Evaluating the Efficacy and Safety of Artesunate","phase":"PHASE2","overall_status":"RECRUITING","enrollment_count":90,"lead_sponsor_name":"Amivas Inc.","has_results":false},{"nct_id":"NCT03629080","title":"A Study of CMV Vaccine (HB-101) in Kidney Transplant Patients","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":83,"lead_sponsor_name":"Hookipa Biotech GmbH","has_results":true},{"nct_id":"NCT06021210","title":"Letermovir for the Prevention of CMV Infection in HSCT Recipients Based on the Outcome of mNGS","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"The First Affiliated Hospital of Soochow University","has_results":false},{"nct_id":"NCT02136797","title":"Trial of Third Party Donor Derived CMVpp65 Specific T-cells for The Treatment of CMV Infection or Persistent CMV Viremia After Allogeneic Hematopoietic Stem Cell Transplantation","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":77,"lead_sponsor_name":"Memorial Sloan Kettering Cancer Center","has_results":true},{"nct_id":"NCT07225972","title":"Phase 3 Randomized Trial for Refractory ADV or CMV Infection With Family Matched CTLs and Standard of Care (SOC) vs SOC Alone","phase":"PHASE3","overall_status":"NOT_YET_RECRUITING","enrollment_count":69,"lead_sponsor_name":"New York Medical College","has_results":false},{"nct_id":"NCT03940586","title":"Letermovir Treatment in Pediatric Participants Following Allogeneic Haematopoietic Stem Cell Transplantation (HSCT) (MK-8228-030)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":65,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02680743","title":"Cytomegalovirus Testing and Intervention Protocol for Newborn Nursery and Newborn Intensive Care Unit","phase":"NA","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University of Nebraska","has_results":false},{"nct_id":"NCT03916497","title":"Anti-CMV Cellular Immunity Quantification Using an IGRA Test in Kidney Transplant récipients and Hemodialysis Patients, Comparison to Control Patients","phase":"","overall_status":"COMPLETED","enrollment_count":60,"lead_sponsor_name":"University Hospital, Grenoble","has_results":false},{"nct_id":"NCT04934527","title":"Association of T Gamma Delta-CD16+ Cells and Anti-CMV Immunoglobulins in the Prevention of CMV Infection","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"University Hospital, Bordeaux","has_results":false},{"nct_id":"NCT04320303","title":"CMV Infection and Immune Intervention After Transplantation","phase":"NA","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT06075927","title":"Multivirus-specific T Cells in the Treatment of Refractory CMV and/or EBV Infection After Allo-HSCT","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":29,"lead_sponsor_name":"Peking University People's Hospital","has_results":false},{"nct_id":"NCT05914675","title":"Letermovir for Primary Prophylaxis of Cytomegalovirus Infection After R+HID-HSCT","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":21,"lead_sponsor_name":"Institute of Hematology & Blood Diseases Hospital, China","has_results":false},{"nct_id":"NCT04153279","title":"CMV-TCR-T Cells for CM Virus Infection After HSCT","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":17,"lead_sponsor_name":"Hebei Yanda Ludaopei Hospital","has_results":false},{"nct_id":"NCT05140187","title":"CMV-TCR-T Cells for CMV Infection After Allogenic HSCT","phase":"PHASE1","overall_status":"UNKNOWN","enrollment_count":12,"lead_sponsor_name":"Chinese PLA General Hospital","has_results":false},{"nct_id":"NCT07488481","title":"Renal Ex Vivo SYN002 Perfusion to Eliminate CMV Transmission","phase":"EARLY_PHASE1","overall_status":"NOT_YET_RECRUITING","enrollment_count":12,"lead_sponsor_name":"University Health Network, Toronto","has_results":false},{"nct_id":"NCT03798301","title":"Treatment of Cytomegalovirus (CMV) Infections With Viral-Specific T Cells","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":3,"lead_sponsor_name":"University of Wisconsin, Madison","has_results":false},{"nct_id":"NCT03369912","title":"A Study to Evaluate CSJ148 in Pregnant Women With Primary HCMV Infection","phase":"PHASE2","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT01945619","title":"Allogeneic Virus-Specific Cytotoxic T-Lymphocytes(CTL), Persistent/Recurrent Viral Infection Post-HSCT (EAP CHALLAH)","phase":"","overall_status":"NO_LONGER_AVAILABLE","enrollment_count":null,"lead_sponsor_name":"Baylor College of Medicine","has_results":false}],"total":37},"guidelines":[],"source":"Drug Landscape verified database"}